98%
921
2 minutes
20
Rationale: To evaluate the effect of pharmaceutical care provided by clinical pharmacists during COVID-19 treated with nirmatrelvir/ritonavir in heart transplant (HT) patients.
Patient Concerns: Three HT recipients were admitted to the hospital after testing positive for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) nucleic acid. Due to factors such as underlying immunosuppression resulting from the heart transplantation and the use of antirejection medications, patients who have undergone heart transplantation and become infected with SARS-CoV-2 exhibit significant differences in pathological responses and drug metabolism in the body compared to other patients. During the treatment period with nirmatrelvir/ritonavir, clinical pharmacists provided comprehensive pharmaceutical care for these patients throughout the course.
Diagnoses: After heart transplantation, testing positive for SARS-CoV-2 nucleic acid.
Interventions: During the treatment of the 3 patients with nirmatrelvir/ritonavir for COVID-19, clinical pharmacists provided pharmaceutical care from aspects such as medication indications, dosage administration, drug adjustments, drug interactions, and adverse reaction monitoring, in order to develop individualized medication regimens for the patients.
Outcomes: Clinical pharmacists actively predicted, identified, and resolved issues that arose during the treatment of HT recipients with nirmatrelvir/ritonavir. They monitored the blood concentration of tacrolimus and the interactions between nirmatrelvir/ritonavir and other medications throughout the treatment process. All 3 patients were cured and discharged from the hospital.
Lessons: During the treatment process, managing complex polypharmacy posed significant challenges. Clinical pharmacists implemented individualized therapeutic drug monitoring to optimize antiviral efficacy. Through rational and effective pharmaceutical care, the clinical cure rate for HT recipients infected with COVID-19 was improved.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212775 | PMC |
http://dx.doi.org/10.1097/MD.0000000000043122 | DOI Listing |
J Med Internet Res
September 2025
Chulalongkorn University, Bangkok, Thailand.
Background: The interprofessional educational curriculum for patient and personnel safety is of critical importance, especially in the context of the COVID-19 pandemic, to prepare junior multiprofessional teams for emergency settings.
Objective: This study aimed to evaluate the effectiveness of an innovative interprofessional educational curriculum that integrated medical movies, massive open online courses (MOOCs), and 3D computer-based or virtual reality (VR) simulation-based interprofessional education (SimBIE) with team co-debriefing to enhance interprofessional collaboration and team performance using Team Strategies and Tools to Enhance Performance and Patient Safety (TeamSTEPPS). This study addressed 3 key questions.
Am J Respir Cell Mol Biol
September 2025
University of Toronto, Interdepartmental Division of Critical Care Medicine, Toronto, Ontario, Canada.
Post-Intensive Care Syndrome (PICS) is a serious condition involving physical weakness, depression, and cognitive impairment that develop during or after an intensive care unit (ICU) stay, often resulting in long-term declines in quality of life. Patients with acute respiratory distress syndrome (ARDS) and severe COVID-19 are at particularly high risk, yet the molecular mechanisms underlying PICS remain poorly understood. Here, we identify impaired Apelin-APJ signaling as a potential contributor to PICS pathogenesis via disruption of inter-organ homeostasis.
View Article and Find Full Text PDFPLOS Digit Health
September 2025
Department of Dermatology, Stanford University, Stanford, California, United States of America.
Large Language Models (LLMs) are increasingly deployed in clinical settings for tasks ranging from patient communication to decision support. While these models demonstrate race-based and binary gender biases, anti-LGBTQIA+ bias remains understudied despite documented healthcare disparities affecting these populations. In this work, we evaluated the potential of LLMs to propagate anti-LGBTQIA+ medical bias and misinformation.
View Article and Find Full Text PDFPLoS One
September 2025
Geriatric Medicine Center, Department of Nursing, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Background: In recent years, with the expanding use of novel therapeutics such as immune checkpoint inhibitors and monoclonal antibodies, reports of drug-induced vitiligo have been increasing. This study aimed to identify drugs associated with vitiligo using the FDA Adverse Event Reporting System (FAERS).
Methods: A retrospective disproportionality analysis was performed on FAERS reports from the first quarter of 2004 to the fourth quarter of 2024.
JACC Cardiovasc Imaging
September 2025
Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
Background: Coronary computed tomography angiography (CTA)-derived plaque burden is associated with the risk of cardiovascular events and is expected to be used in clinical practice. Understanding the normative values of computed tomography-based quantitative plaque volume in the general population is clinically important for determining patient management.
Objectives: This study aimed to investigate the distribution of plaque volume in the general population and to develop nomograms using MiHEART (Miami Heart Study) at Baptist Health South Florida, a large community-based cohort study.